Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.000
+0.090 (4.71%)
Jun 27, 2025, 4:00 PM - Market closed

Armata Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-0.43-18.92-69.05-36.92-23.16-22.18
Upgrade
Depreciation & Amortization
1.391.330.970.891.171.11
Upgrade
Loss (Gain) From Sale of Assets
--0.08---
Upgrade
Stock-Based Compensation
3.142.890.943.112.883.48
Upgrade
Other Operating Activities
-37.04-20.7529.28--1.250.2
Upgrade
Change in Accounts Payable
-2.82-3.760.043.670.180.54
Upgrade
Change in Other Net Operating Assets
1.221.66-9.69-3.23-3.41-1.42
Upgrade
Operating Cash Flow
-34.55-37.55-47.42-32.48-23.58-18.27
Upgrade
Capital Expenditures
-1.73-1.88-8.14-2.21-1.3-0.82
Upgrade
Sale of Property, Plant & Equipment
--0.01---
Upgrade
Investing Cash Flow
-1.73-1.88-8.13-2.21-1.3-0.82
Upgrade
Short-Term Debt Issued
-----0.72
Upgrade
Long-Term Debt Issued
-34.8954.03---
Upgrade
Total Debt Issued
1034.8954.03--0.72
Upgrade
Net Debt Issued (Repaid)
1034.8954.03--0.72
Upgrade
Issuance of Common Stock
0.090.130.0144.5226.9323.06
Upgrade
Repurchase of Common Stock
-0.08-0.06-0.04---
Upgrade
Other Financing Activities
----0.5-1.41-0.57
Upgrade
Financing Cash Flow
10.0134.9653.9944.0225.5223.21
Upgrade
Net Cash Flow
-26.26-4.47-1.579.320.644.12
Upgrade
Free Cash Flow
-36.28-39.43-55.57-34.69-24.88-19.09
Upgrade
Free Cash Flow Margin
-771.97%-762.08%-1226.91%-629.85%-556.08%-2320.05%
Upgrade
Free Cash Flow Per Share
-1.00-0.67-1.54-1.01-1.03-1.16
Upgrade
Levered Free Cash Flow
-30.48-29.4-27.75-24.24-16.82-9.83
Upgrade
Unlevered Free Cash Flow
-22.66-22.69-26.11-24.24-16.78-9.44
Upgrade
Change in Net Working Capital
0.2-1.5-5.692.934.64-0.29
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q